16. McCudden CR, Hains MD, Kimple RJ, Siderovski DP, Willard FS (2005) G- protein signaling: back to the future. Cell Mol Life Sci 62: 551–577. 17. Smrcka AV (2008) G protein bc subunits: Central mediators of G protein- coupled receptor signaling. Cell Mol Life Sci 65: 2191–2214. 18. Hirsch E, Katanaev VL, Garlanda C, Azzolino O, Pirola L, et al. (2000) Central role for G protein-coupled phosphoinositide 3-kinase c in inflammation. Science 287: 1049–1053. 19. Barr AJ, Ali H, Haribabu B, Snyderman R, Smrcka AV (2000) Identification of a region at the N-terminus of phospholipase C-b3 that interacts with G protein bc subunits. Biochemistry 39: 1800–1806. 20. Ferry X, Eichwald V, Daeffler L, Landry Y (2001) Activation of bc subunits of Gi2 and Gi3 proteins by basic secretagogues induces exocytosis through phospholipase Cb and arachidonate release through phospholipase Cc in mast cells. J Immunol 167: 4805–4813. 21. Laffargue M, Calvez R, Finan P, Trifilieff A, Barbier M, et al. (2002) Phosphoinositide 3-kinase c is an essential amplifier of mast cell function. Immunity 16: 441–451. 22. Kuehn HS, Gilfillan AM (2007) G protein-coupled receptors and the modification of FceRI-mediated mast cell activation. Immunol Lett 113: 59–69. 23. Nino G, Hu A, Grunstein JS, Grunstein MM (2010) Mechanism of glucocorticoid protection of airway smooth muscle from proasthmatic effects of long-acting b2-adrenoceptor agonist exposure. J Allergy Clin Immunol 125: 1020–1027. 24. Hakonarson H, Grunstein MM (1998) Autologously up-regulated Fc receptor expression and action in airway smooth muscle mediates its altered responsiveness in the atopic asthmatic sensitized state. Proc Natl Acad Sci USA 95: 5257–5262. 25. Chang M, Zhang L, Tam JP, Sanders-Bush E (2000) Dissecting G protein- coupled receptor signaling pathways with membrane-permeable blocking peptides. J Biol Chem 275: 7021–7029. 26. Casey LM, Pistner AR, Belmonte SL, Migdalovich D, Stolpnik O, et al. (2010) Small molecule disruption of Gbc signaling inhibits the progression of heart failure. Circ Res107: 532–539. 27. Lehmann DM, Seneviratne AM, Smrcka AV (2008) Small molecule disruption of G protein bc subunit signaling inhibits neutrophil chemotaxis and inflammation. Mol Pharmacol 73: 410–418. 28. van Schalkwyk E, Strydom K, Williams Z, Venter L, Leichtl S, et al. (2005) Roflumilast, an oral, once-daily phosphodiesterase 4 inhibitor, attenuates allergen-induced asthmatic reactions. J Allergy Clin Immunol 116: 292–298. 29. Hansen G, Jin S, Umetsu DT, Conti M (2000) Absence of muscarinic cholinergic airway responses in mice deficient in the cyclic nucleotide phosphodiesterase PDE4D. Proc Natl Acad Sci U S A 97: 6751–6756. 30. Kanehiro A, Ikemura T, Makela MJ, Lahn M, Joetham A, et al. (2001) Inhibition of phosphodiesterase 4 attenuates airway hyperresponsiveness and airway inflammation in a model of secondary allergen challenge. Am J Respir Crit Care Med 163: 173–184. 31. Tang HF, Song YH, Chen JC, Chen JQ, Wang P (2005) Upregulation of phosphodiesterase-4 in the lung of allergic rats. Am J Respir Crit Care Med 171: 823–828. 32. Sun JG, Deng YM, Wu X, Tang HF, Deng JF, et al. (2006) Inhibition of phosphodiesterase activity, airway inflammation and hyperresponsiveness by PDE4 inhibitor and glucocorticoid in a murine model of allergic asthma. Life Sci 79: 2077–2085. 33. Chapman RW, House A, Jones H, Richard J, Celly C, et al. (2007) Effect of inhaled roflumilast on the prevention and resolution of allergen-induced late phase airflow obstruction in Brown Norway rats. Eur J Pharmacol 571: 215–221. 34. Grunstein MM, Hakonarson H, Leiter J, Chen M, Whelan R, et al. (2002) IL- 13-dependent autocrine signaling mediates altered responsiveness of IgE- sensitized airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 282: L520–L528. 35. Grunig G, Warnock M, Wakil AE, Venkayya R, Brombacher F, et al. (1998) Requirement for IL-13 independently of IL-4 in experimental asthma. Science 282: 2261–2263. 36. Wills-Karp M, Luyimbazi J, Xu X, Schofield B, Neben TY, et al. (1998) Interleukin-13: central mediator of allergic asthma. Science 282: 2258–2260. 37. Kmiecik TE, Shalloway D (1987) Activation and suppression of pp60c-src transforming ability by mutation of Its primary sites of tyrosine phosphorylation. Cell 49: 65–73. 38. Le Jeune IR, Shepherd M, Van Heeke G, Houslay MD, Hall IP (2002) Cyclic AMP-dependent transcriptional up-regulation of phosphodiesterase 4D5 in human airway smooth muscle cells. Identification and characterization of a novel PDE4D5 promoter. J Biol Chem 277: 35980–35989. 39. Billington CK, Le Jeune IR, Young KW, Hall IP (2008) A major functional role for phosphodiesterase 4D5 in human airway smooth muscle cells. Am J Respir Cell Mol Biol 38: 1–7. 40. Deshpande DA, Penn RB (2006) Targeting G protein-coupled receptor signaling in asthma. Cell Signal 18: 2105–2120. 41. McGraw DW, Elwing JM, Fogel KM, Wang WC, Glinka CB, et al. (2007) Crosstalk between Gi and Gq/Gs pathways in airway smooth muscle regulates bronchial contractility and relaxation. J Clin Invest 117: 1391–1398. G Protein bc-Subunit Signaling in Asthma 42. Stephens L, Smrcka A, Cooke FT, Jackson TR, Sternweis PC, et al. (1994) A novel, phosphoinositide 3-kinase activity in myeloid-derived cells is activated by G-protein bc-subunits. Cell 77: 83–93. 43. Ikeda SR (1996) Voltage-dependent modulation of N-type calcium channels by G-protein bc subunits. Nature 380: 255–258. 44. Conway AM, Rakhit S, Pyne S, Pyne NJ (1999) Platelet-derived growth-factor stimulation of the p42/p44 mitogen activated protein kinase pathway in airway smooth muscle: role of pertussis-toxin-sensitive G-proteins, c-Src tyrosine kinases and phosphoinositide 3-kinase. Biochem J 337: 171–177. 45. Welch HCE, Coadwell WJ, Ellson CD, Ferguson GJ, Andrews SR, et al. (2002) P-Rex1, a PtdIns(3,4,5)P3- and Gbc-regulated guanine-nucleotide exchange factor for Rac. Cell 108: 809–821. 46. Li Z, Jiang H, Xie W, Zhang Z, Smrcka AV, et al. (2000) Roles of PLC-b2 and - b3 and PI3Kc in chemoattractant-mediated signal transduction. Science 287: 1046–1049. 47. Abebe W, Mustafa SJ (1998) A1 adenosine receptor-mediated Ins(1,4,5)P3 generation in allergic rabbit airway smooth muscle. Am J Physiol 275: L990–L997. 48. Hakonarson H, Grunstein MM (1998) Regulation of second messengers associated with airway smooth muscle contraction and relaxation. Am J Respir Crit Care Med 158: S115–S122. 49. Kinyanjui MW, Fixman ED (2008) Cell-penetrating peptides and proteins: new inhibitors of allergic disease. Can J Physiol Pharmacol 86: 1–7. 50. Schroder S, Lohse MJ (2000) Quantification of the tissue levels and function of the G-protein regulator phosducin-like protein (PhlP). Naunyn-Schmiedeberg’s Arch Pharmacol 362: 435–439. 51. Thibault C, Sganga MW, Miles MF (1997) Interaction of phosducin-like protein with G protein bc subunits. J Biol Chem 272: 12253–12256. 52. Savage JR, McLaughlin JN, Skiba NP, Hamm HE, Willardson BM (2000) Functional roles of the two domains of phosducin and phosducin-like protein. J Biol Chem 275: 30399–30407. 53. Humrich J, Bermel C, Bunemann M, Harmark L, Frost R, et al. (2005) Phosducin-like protein regulates G-Protein bc folding by interaction with tailless complex polypeptide-1. J Biol Chem 280: 20042–20050. 54. Duan W, Chan JH, Wong CH, Leung BP, Wong WS (2004) Anti-inflammatory effects of mitogen-activated protein kinase kinase inhibitor U0126 in an asthma mouse model. J Immunol 172: 7053–7059. 55. Ohnishi H, Takeda K, Domenico J, Lucas JJ, Miyahara N, et al. (2009) Mitogen-activated protein kinase/extracellular signal-regulated kinase 1/2- dependent pathways are essential for CD8+ T cell-mediated airway hyperre- sponsiveness and inflammation. J Allergy Clin Immunol 123: 249–257. 56. Krymskaya VP, Panettieri RA, Jr. (2007) Phosphodiesterases regulate airway smooth muscle function in health and disease. Curr Top Dev Biol 79: 61–74. 57. Trian T, Burgess JK, Niimi K, Moir LM, Ge Q, et al. (2011) b2-agonist Induced cAMP Is decreased in asthmatic airway smooth muscle due to increased PDE4D. PloS ONE 6(5): e20000. 58. Laporte JC, Moore PE, Baraldo S, Jouvin MH, Church TL, et al. (2001) Direct effects of interleukin-13 on signaling pathways for physiological responses in cultured human airway smooth muscle cells. Am J Respir Crit Care Med 164: 141–148. 59. Moynihan B, Tolloczko B, Michoud MC, Tamaoka M, Ferraro P, et al. (2008) MAP kinases mediate interleukin-13 effects on calcium signaling in human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 295: L171–L177. 60. Lee PJ, Zhang X, Shan P, Ma B, Lee CG, et al. (2006) ERK1/2 mitogen- activated protein kinase selectively mediates IL-13-induced lung inflammation and remodeling in vivo. J Clin Invest 116: 163–173. 61. Trifilieff A, El-Hashim A, Bertrand C (2000) Time course of inflammatory and remodeling events in a murine model of asthma: effect of steroid treatment Am J Physiol Lung Cell Mol Physiol 279: L1120–L1128. 62. Taube C, Dakhama A, Rha YH, Takeda K, Joetham A, et al. (2003) Transient neutrophil infiltration after allergen challenge is dependent on specific antibodies and Fc gamma III receptors. J Immunol 170: 4301–4309. 63. Mizutani N, Goshima H, Nabe T, Yoshino S (2011) Establishment and characterization of a murine model for allergic asthma using allergen-specific IgE monoclonal antibody to study pathological roles of IgE. Immunol Lett. In press. 64. Keir SD, Spina D, Douglas G, Herd C, Page CP (2011) Airway responsiveness in an allergic rabbit model. J Pharmacol Toxicol Methods 64: 167–195. 65. Nocker RET, Out TA, Weller FR, Mul EPJ, Jansen HM, et al. (1999) Influx of neutrophils into the airway lumen at 4 h after segmental allergen challenge in asthma. Int Arch Allergy Immunol 119: 45–53. 66. Goldie RG, Spina D, Henry PJ, Lulich KM, Paterson JW (1986) In vitro responsiveness of human asthmatic bronchus to carbachol, histamine, ß- adrenoceptor agonists and theophylline. Br J Clin Pharmacol 22: 669–676. 67. Bai TR, Mak JC, Barnes PJ (1992) A comparison of beta-adrenergic receptors and in vitro relaxant responses to isoproterenol in asthmatic airway smooth muscle. Am J Respir Cell Mol Biol 6: 647–651. 68. Zschauer AOA, Sielczak MW, Wanner A (1999) Altered contractile sensitivity of isolated bronchial artery to phenylephrine in ovalbumin-sensitized rabbits. J Appl Physiol 86: 1721–1727. 69. Grunstein MM, Tanaka DT, Grunstein JS (1984) Mechanism of substance P- induced bronchoconstriction in maturing rabbit. J Appl Physiol 57: 1238–1246. PLoS ONE | www.plosone.org 15 February 2012 | Volume 7 | Issue 2 | e32078